Oxaliplatin Completed Phase 2 Trials for Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00296816TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary